Agnieszka B.
- Country
- Poland
- Department
- Ośrodek Badań Klinicznych Clinsante
Research Overview
- Adjunctive Aticaprant and Antidepressant Therapy for Relapse Prevention in Major Depressive Disorder with Moderate-to-Severe Anhedonia: A Randomized, Double-Blind Study
- Long-term Safety and Efficacy of Aticaprant as Adjunctive Therapy in Adults and Elderly with Major Depressive Disorder: An Open-label Study
- Efficacy and Safety of Aticaprant as Adjunctive Therapy in Adults with Major Depressive Disorder and Anhedonia Unresponsive to Antidepressants
Data & Insights
Has run more than one trial at 96 of 235 partner sites.
Specializations
Depression Treatment Research
This investigator specializes in studying adjunctive therapies for Major Depressive Disorder (MDD), with particular focus on developing treatment solutions for patients who show inadequate response to standard antidepressant medications.
- Treatment-Resistant Depression
- Antidepressant Augmentation Strategies
- Long-term Depression Management
The research encompasses novel therapeutic approaches using adjunctive medications alongside conventional antidepressants.
Specialized Depression Subtypes
The investigator demonstrates particular expertise in addressing specific manifestations of depression, with specialized focus on depression accompanied by anhedonia symptoms.
- Moderate-to-Severe Anhedonia
- Complex Depressive Disorders
- Symptom-Specific Interventions
Their work involves evaluating targeted therapeutic approaches for distinct depression subtypes.
Therapeutic Innovation
The investigator's research portfolio includes studies of novel pharmaceutical compounds for depression treatment, including SEP-363856 and aticaprant.
- Novel Antidepressant Development
- Relapse Prevention Strategies
- Safety and Efficacy Assessment
Their work focuses on expanding therapeutic options for depression treatment through innovative medication approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.